Sophiris Bio Corp   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: La Jolla California United States (2002)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2006
NCT00379561
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

topsalysin (6 trials)

Drugs in Phase 2 Trials (1)

prx-321 (1 trial)

Drugs in Phase 1 Trials (1)

psa-pah1 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glioblastoma (Phase 2)

Hyperplasia (Phase 3)

Lower Urinary Tract Symptoms (Phase 3)

Prostatic Hyperplasia (Phase 3)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 3